Gadobutrol OverviewGadobutrol (INN) (Gd-DO3A-butrol) is a gadolinium-based MRI contrast agent (GBCA). It received marketing approval in Canada and in the United States. As of 2007, it was the only GBCA approved at 1.0 molar concentrations. Gadobutrol is marketed by Bayer AG as Gadovist, and by Bayer HealthCare Pharmaceuticals as Gadavist. Contents 1 Medical uses 2 Adverse effects 3 Use in specif...
Read more Gadobutrol Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Gadobutrol
Recent Gadobutrol Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 1mmol/ml
- Solution: 1.20944gm/2ml (604.72mg/ml), 18.1416gm/30ml (604.72mg/ml), 39.3068gm/65ml (604.72mg/ml), 4.5354gm/7.5ml (604.72mg/ml), 6.0472gm/10ml (604.72mg/ml), 9.0708gm/15ml (604.72mg/ml)
Other drugs which contain Gadobutrol or a similar ingredient: (1 result)
- GADAVIST Gadobutrol